Transforming the understanding
and treatment of mental illnesses.

Multimedia

Featured Video

Discover NIMH: Drug Discovery and Development

One of the most exciting recent breakthroughs from research funded by the National Institute of Mental Health (NIMH) is the development of a fast-acting medication for treatment-resistant depression based on ketamine. This treatment is bringing new hope to people and families affected by major depression.

Health Topics

Anxiety Disorders
Attention-Deficit/Hyperactivity Disorder (ADHD)
Autism Spectrum Disorder (ASD)
Bipolar Disorder
Borderline Personality Disorder
COVID-19
Depression
Disruptive Mood Dysregulation Disorder
Eating Disorders
Generalized Anxiety Disorder
HIV/AIDS
Obsessive-Compulsive Disorder (OCD)
Panic Disorder
Post-Traumatic Stress Disorder (PTSD)
Psychosis
Schizophrenia
Social Anxiety Disorder
Suicide
Traumatic Events

Populations

Children and Adolescents
Global Mental Health
Men’s Mental Health
Military Service Members
Older Adults
Sexual and Gender Minority
Women’s Mental Health

Research

Basic Research
Brain Anatomy and Physiology
BRAIN Initiative
Clinical Research and Trials
Genetics
Health Disparities
Mental Health Services Research
Prevention
RDoC
Recovery Act
Research Funding
Training
Treatments

Other

Institute Announcements

NIMH Information Resource Center

Available in English and español

Phone:  1-866-615-6464
Live Online Chat:  Talk to a representative
Email:  nimhinfo@nih.gov
Hours: 8:30 a.m. – 5 p.m. ET, M-F

Mail:  National Institute of Mental Health
Office of Science Policy, Planning, and Communications
6001 Executive Boulevard, Room 6200, MSC 9663
Bethesda, MD 20892-9663